The DOI matches its Crossref record; 68 of the 73 references it cites were found in a registry or an index.
(S)-(−)-Cotinine, the Major Brain Metabolite of Nicotine, Stimulates Nicotinic Receptors to Evoke [3H]Dopamine Release from Rat Striatal Slices in a Calcium-Dependent Manner
Abstract
Cotinine, a major peripheral metabolite of nicotine, has recently been shown to be the most abundant metabolite in rat brain after peripheral nicotine administration. However, little attention has been focused on the contribution of cotinine to the pharmacological effects of nicotine exposure in either animals or humans. The present study determined the concentration-response relationship for (S)-(-)-cotinine-evoked 3H overflow from superfused rat striatal slices preloaded with [3H]dopamine ([3H]DA) and whether this response was mediated by nicotinic receptor stimulation. (S)-(-)-Cotinine (1 microM to 3 mM) evoked 3H overflow from [3H]DA-preloaded rat striatal slices in a concentration-dependent manner with an EC50 value of 30 microM, indicating a lower potency than either (S)-(-)-nicotine or the active nicotine metabolite, (S)-(-)-nornicotine. As reported for (S)-(-)-nicotine and (S)-(-)-nornicotine, desensitization to the effect of (S)-(-)-cotinine was observed. The classic nicotinic receptor antagonists mecamylamine and dihydro-beta-erythroidine inhibited the response to (S)-(-)-cotinine (1-100 microM). Additionally, 3H overflow evoked by (S)-(-)-cotinine (10-1000 microM) was inhibited by superfusion with a low calcium buffer. Interestingly, over the same concentration range, (S)-(-)-cotinine did not inhibit [3H]DA uptake into striatal synaptosomes. These results demonstrate that (S)-(-)-cotinine, a constituent of tobacco products and the major metabolite of nicotine, stimulates nicotinic receptors to evoke the release of DA in a calcium-dependent manner from superfused rat striatal slices. Thus, (S)-(-)-cotinine likely contributes to the neuropharmacological effects of nicotine and tobacco use.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“both nicotine59 and cotinine60 have been shown to facilitate dopamine release”
From β2-Nicotinic Acetylcholine Receptor Availability During Acute and Prolonged Abstinence From Tobacco Smoking (2009) · cites this paper as [60]
In the citing paper
“Dopamine release has been associated with the feeling of craving58, and both nicotine59 and cotinine60 have been shown to facilitate dopamine release, thus the prolonged partial occupancy of the receptor by nicotine or cotinine, may contribute to the feelings of craving that are reported 2 h after the last cigarette and throughout the first week of abstinence.”
From β2-Nicotinic Acetylcholine Receptor Availability During Acute and Prolonged Abstinence From Tobacco Smoking (2009) · cites this paper as [60]
In the citing paper
“The rather high circulating plasma cotinine levels after nicotine ingestion, coupled with findings that cotinine stimulates nAChRs, has prompted the suggestion that cotinine per se may have biological effects (Dwoskin et al., 1999;O'Leary et al., 2008).”
From Nicotinic receptor-mediated reduction in l-DOPA-induced dyskinesias may occur via desensitization (2010) · cites this paper as Dwoskin et al., 1999
Citations
Cites
Bradford, M. M. (1976) · Analytical Biochemistry · doi:10.1016/0003-2697(76)90527-3 · Cited by 255,302
The mesolimbic dopaminergic system is implicated in the reinforcing effects of nicotine
Corrigall, W. A., Franklin, K. B. J., Coen, K. M., & Clarke, P. B. S. (1992) · Psychopharmacology · doi:10.1007/bf02245149 · Cited by 829
Corrigall, W. A., Coen, K. M., & Adamson, K. L. (1994) · Brain Research · doi:10.1016/0006-8993(94)90401-4 · Cited by 740
Nicotine preferentially stimulates dopamine release in the limbic system of freely moving rats
Imperato, A., Mulas, A., & Di Chiara, G. (1986) · European Journal of Pharmacology · doi:10.1016/0014-2999(86)90629-1 · Cited by 693
Presynaptic regulation of neurotransmitter release in the brain: Facts and hypothesis
Chesselet, M.-F. (1984) · Neuroscience · doi:10.1016/0306-4522(84)90058-7 · Cited by 577
Cotinine disposition and effects
Benowitz, N. L., Kuyt, F., Jacob, P., Jones, R. T., & Osman, A.-L. (1983) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1983.222 · Cited by 484
Relation of nicotine yield of cigarettes to blood nicotine concentrations in smokers.
Russell, M. A., Jarvis, M., Iyer, R., & Feyerabend, C. (1980) · BMJ · doi:10.1136/bmj.280.6219.972 · Cited by 465
A Major Role for CYP2A6 in Nicotine C-Oxidation by Human Liver Microsomes
Messina, E. S., Tyndale, R. F., & Sellers, E. M. (1997) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)36947-2 · Cited by 455
Nicotine metabolism defect reduces smoking
Pianezza, M. L., Sellers, E. M., & Tyndale, R. F. (1998) · Nature · doi:10.1038/31623 · Cited by 437
Role of human cytochrome P4502A6 in C-oxidation of nicotine.
Nakajima, M., Yamamoto, T., Nunoya, K., Yokoi, T., Nagashima, K., Inoue, K., Funae, Y., Shimada, N., Kamataki, T., & Kuroiwa, Y. (1996) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(25)08453-3 · Cited by 419
Research works printed but not linked: 3
- Balfour, 1993, The role of brain dopamine systems in the psychopharmacological responses to nicotine., Asia Pacific J Pharmacol, 8, 153
- Flammang, 1992, Nicotine metabolism by cDNA expressed human cytochrome P-450s., Biochem Arch, 8, 1
- McCracken, 1992, Cotinine formation by cDNA-expressed human cytochromes P450., Med Sci Res, 20, 877
Cited by
Sorted by citations
Nicotine and the adolescent brain: insights from an animal model
Slotkin, T. (2002) · Neurotoxicology and Teratology · doi:10.1016/s0892-0362(02)00199-x · Cited by 284
Association of tobacco and lead exposures with attention-deficit/hyperactivity disorder
Froehlich, T. E., Lanphear, B. P., Auinger, P., Hornung, R., Epstein, J. N., Braun, J., & Kahn, R. S. (2009) · Pediatrics · doi:10.1542/peds.2009-0738 · Cited by 234
Trauth, J. A., Seidler, F. J., & Slotkin, T. A. (2000) · Brain Research · doi:10.1016/s0006-8993(00)02208-3 · Cited by 189
Cosgrove, K. P., Batis, J., Bois, F., Maciejewski, P. K., Esterlis, I., Kloczynski, T., Stiklus, S., Krishnan-Sarin, S., O’Malley, S., Perry, E., et al. (2009) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2009.41 · Cited by 165
Demethylation of the aryl hydrocarbon receptor repressor as a biomarker for nascent smokers
Philibert, R. A., Beach, S. R. H., & Brody, G. H. (2012) · Epigenetics · doi:10.4161/epi.22520 · Cited by 157
Clemens, K. J., Caillé, S., Stinus, L., & Cador, M. (2009) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145709000273 · Cited by 153
Ahankar, H., Ramazani, A., Ślepokura, K. A., Lis, T., & Joo, S. W. (2016) · Green Chemistry · doi:10.1039/c6gc00157b · Cited by 127
Tucker, J. W., & Stephenson, C. R. J. (2011) · Organic Letters · doi:10.1021/ol202178t · Cited by 122
Barreto, G. E., Iarkov, A., & Echeverrı́a, V. (2015) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2014.00340 · Cited by 119
Miksys, S. L., Hoffmann, E. B., & Tyndale, R. F. (2000) · Biochemical Pharmacology · doi:10.1016/s0006-2952(00)00281-1 · Cited by 114
Ghosheh, O. A., Dwoskin, L. P., Miller, D. K., & Crooks, P. A. (2001) · PubMed · Cited by 111
Self-citationGhosheh, O., Dwoskin, L. P., Li, W.-K., & Crooks, P. A. (1999) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(24)14955-0 · Cited by 108
Self-citationPyridine alkaloids with activity in the central nervous system
Lin, S. X., Curtis, M. A., & Sperry, J. (2020) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2020.115820 · Cited by 106
Hoffman, A. C., & Evans, S. E. (2012) · Nicotine & Tobacco Research · doi:10.1093/ntr/nts192 · Cited by 93
Siu, E. C. K., & Tyndale, R. F. (2006) · Molecular Pharmacology · doi:10.1124/mol.106.032086 · Cited by 93
Echeverría, V., Iarkov, A., & Aliev, G. (2016) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2016.01.002 · Cited by 95
Cotinine: Pharmacologically Active Metabolite of Nicotine and Neural Mechanisms for Its Actions
Tan, X., Vrana, K. E., & Ding, Z. (2021) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2021.758252 · Cited by 86
Rehani, K., Scott, D. A., Renaud, D. E., Hamza, H., Williams, L., Wang, H., & Martin, M. (2008) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2007.12.003 · Cited by 83
Nicotinic receptor-mediated reduction in l-DOPA-induced dyskinesias may occur via desensitization
Bordia, T., Campos, C., McIntosh, J. M., & Quik, M. (2010) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.109.162396 · Cited by 82
Buccafusco, J. J., & Terry, A. V. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.06.102 · Cited by 79
Biological basis of tobacco addiction: Implications for smoking-cessation treatment
Jiloha, R. C. (2010) · Indian Journal of Psychiatry · doi:10.4103/0019-5545.74303 · Cited by 75
Rodent models for nicotine withdrawal
Chellian, R., Behnood‐Rod, A., Bruijnzeel, D. M., Wilson, R., Pandy, V., & Bruijnzeel, A. W. (2021) · Journal of Psychopharmacology · doi:10.1177/02698811211005629 · Cited by 71
Grizzell, J. A., Iarkov, A., Holmes, R., Mori, T., & Echeverrı́a, V. (2014) · Behavioural Brain Research · doi:10.1016/j.bbr.2014.03.047 · Cited by 65
The potential role of cotinine in the cognitive and neuroprotective actions of nicotine
Buccafusco, J. J., & Terry, A. V. (2003) · Life Sciences · doi:10.1016/s0024-3205(03)00226-1 · Cited by 62
New Insights into the Mechanisms of Action of Cotinine and its Distinctive Effects from Nicotine
Grizzell, J. A., & Echeverrı́a, V. (2014) · Neurochemical Research · doi:10.1007/s11064-014-1359-2 · Cited by 62
Nakada, T., Kiyotani, K., Iwano, S., Uno, T., Yokohira, M., Yamakawa, K., Fujieda, M., Saito, T., Yamazaki, H., Imaida, K., et al. (2012) · The Journal of Toxicological Sciences · doi:10.2131/jts.37.555 · Cited by 51
Hatano, M., & Nishimura, T. (2015) · Angewandte Chemie International Edition · doi:10.1002/anie.201505382 · Cited by 51
Terry, A. V., Buccafusco, J. J., Schade, R. F., Vandenhuerk, L., Callahan, P. M., Beck, W. D., Hutchings, E. J., Chapman, J., Li, P., & Bartlett, M. G. (2012) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.12.043 · Cited by 47
Cotinine selectively activates a subpopulation of α3/α6β2* nicotinic receptors in monkey striatum
O’Leary, K., Parameswaran, N., McIntosh, J. M., & Quik, M. (2008) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.136838 · Cited by 45
Molecular Mechanisms Associated with Nicotine Pharmacology and Dependence
Fowler, C. D., Turner, J. R., & Damaj, M. I. (2019) · Handbook of experimental pharmacology · doi:10.1007/164_2019_252 · Cited by 50
Hauser, S. R., Getachew, B., Oster, S. M., Dhaher, R., Ding, Z., Bell, R. L., McBride, W. J., & Rodd, Z. A. (2011) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2011.01579.x · Cited by 44
Patel, S. P., Grizzell, J. A., Holmes, R., Zeitlin, R., Solomon, R., Sutton, T. L., Rohani, A., Charry, L. C., Iarkov, A., Mori, T., et al. (2014) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2014.00162 · Cited by 41
Isolation and Microsequencing of a Novel Cotinine Receptor
Riah, O., Dousset, J.-C., Bofill-Cardona, E., & Courriére, P. (2000) · Cellular and Molecular Neurobiology · doi:10.1023/a:1007094623775 · Cited by 39
Metabolism and biochemical effects of nicotine for primary care providers
Metz, C. N., Gregersen, P. K., & Malhotra, A. K. (2004) · Medical Clinics of North America · doi:10.1016/j.mcna.2004.06.004 · Cited by 37
Role for α6 nicotinic receptors in l-dopa-induced dyskinesias in parkinsonian mice
Quik, M., Park, K. M., Hrachova, M., Mallela, A., Huang, L. Z., McIntosh, J. M., & Grady, S. R. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.04.029 · Cited by 37
Whole tobacco smoke extracts to model tobacco dependence in animals
Brennan, K. A., Laugesen, M., & Truman, P. (2014) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2014.07.014 · Cited by 39
R-(+) and S-(−) Isomers of Cotinine Augment Cholinergic Responses In Vitro and In Vivo
Terry, A. V., Callahan, P. M., & Bertrand, D. (2014) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.114.219881 · Cited by 30
Vieira‐Brock, P. L., Miller, E. I., Nielsen, S. M., Fleckenstein, A. E., & Wilkins, D. G. (2011) · Journal of Chromatography B · doi:10.1016/j.jchromb.2011.09.026 · Cited by 31
Chemical properties of nicotine and other tobacco-related compounds
Crooks, P. A. (1999) · Elsevier eBooks · doi:10.1016/b978-044450095-3/50005-x · Cited by 30
Self-citationBírošová, L., Lépesová, K., Grabic, R., & Mackuľak, T. (2020) · Environmental Science and Pollution Research · doi:10.1007/s11356-020-07950-x · Cited by 29
Jutkiewicz, E. M., Nicolazzo, D. M., Kim, M. N., & Gnegy, M. E. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1159-y · Cited by 27
Saha, M., & Das, A. R. (2017) · ChemistrySelect · doi:10.1002/slct.201701989 · Cited by 26
Dwoskin, L. P., Teng, L. H., & Crooks, P. A. (2001) · European Journal of Pharmacology · doi:10.1016/s0014-2999(01)01283-3 · Cited by 25
Self-citationRyu, I. S., Kim, J., Seo, S. Y., Yang, J. H., Oh, J. H., Lee, D., Cho, H., Yoon, S. S., Seo, J., Chang, S., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-15161-7 · Cited by 24
Squaramide-catalysed asymmetric cascade reactions of 2,3-dioxopyrrolidines with 3-chlorooxindoles
Wen, J.-B., & Du, D. (2020) · Organic & Biomolecular Chemistry · doi:10.1039/c9ob02663k · Cited by 23
Basic Science and Public Policy: Informed Regulation for Nicotine and Tobacco Products
Fowler, C. D., Gipson, C. D., Kleykamp, B. A., Rupprecht, L. E., Harrell, P. T., Rees, V. W., Gould, T. J., Oliver, J. A., Bağdaş, D., Damaj, M. I., et al. (2017) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntx175 · Cited by 23
Enders, D., Joie, C., & Deckers, K. (2014) · Synthesis · doi:10.1055/s-0033-1340565 · Cited by 22
The Effect of Cotinine on Nicotine- and Cocaine-Induced Dopamine Release in the Nucleus Accumbens
Sziráki, I., Sershen, H. W., Benuck, M., Lipovac, M. N., Hashim, A. T., Cooper, T. B., Allen, D., & Lajtha, Á. (1999) · Neurochemical Research · doi:10.1007/s11064-999-0001-1 · Cited by 21
Polindara‐García, L. A., Montesinos‐Miguel, D., & Vázquez, A. (2015) · Organic & Biomolecular Chemistry · doi:10.1039/c5ob01170a · Cited by 21
Development of an anti-cotinine vaccine to potentiate nicotine-based smoking cessation strategies
Oliver, J. L., Pashmi, G., Barnett, P., Mettens, P., Biemans, R., Monteyne, P., Palmantier, R., Gallagher, T. C., Ramaya, S., & Wonnacott, S. (2007) · Vaccine · doi:10.1016/j.vaccine.2007.08.019 · Cited by 19
Cotinine: A Therapy for Memory Extinction in Post-traumatic Stress Disorder
Mendoza, C., Barreto, G. E., Iarkov, A., Tarasov, V. V., Aliev, G., & Echeverrı́a, V. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-0869-3 · Cited by 22
Hatano, M., & Nishimura, T. (2015) · Angewandte Chemie · doi:10.1002/ange.201505382 · Cited by 20
Bruijnzeel, A. W., Rodrick, G. B., Singh, R. P., Derendorf, H., & Bauzo, R. M. (2011) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2011.08.005 · Cited by 19
Microfluidic immunoassay for rapid detection of cotinine in saliva
Cheng, K., Zhao, W., Liu, S., & Sui, G. (2013) · Biomedical Microdevices · doi:10.1007/s10544-013-9786-4 · Cited by 19
Multiple Motivational Forces Contribute to Nicotine Dependence
Markou, A., & Paterson, N. E. (2008) · Nebraska Symposium on Motivation/The Nebraska symposium on motivation · doi:10.1007/978-0-387-78748-0_5 · Cited by 20
Structural Studies of Nicotinoids: Cotinine versus Nicotine
Uriarte, I., Pérez, C., Caballero‐Mancebo, E., Basterretxea, F. J., Lesarri, A. G., Fernández, J. A., & Cocinero, E. J. (2017) · Chemistry - A European Journal · doi:10.1002/chem.201700023 · Cited by 18
Self-Administration of Cotinine in Wistar Rats: Comparisons to Nicotine
Ding, Z., Gao, Y., Sentir, A. M., & Tan, X. (2020) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.120.000367 · Cited by 16
Cotinine impacts sensory processing in DBA/2 mice through changes in the conditioning amplitude
Wildeboer, K. M., Zheng, L., Choo, K. S., & Stevens, K. E. (2014) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2013.12.005 · Cited by 17
Marusich, J. A., Darna, M., Wilson, A. G., Denehy, E. D., Ebben, A., Deaciuc, A. G., Dwoskin, L. P., Bardo, M. T., Lefever, T. W., Wiley, J. L., et al. (2017) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2017.08.029 · Cited by 16
Self-citationCotinine, a major nicotine metabolite, induces cell proliferation on urothelium in vitro and in vivo
Suzuki, S., Cohen, S. M., Arnold, L. L., Pennington, K. L., Kato, H., Naiki, T., Naiki‐Ito, A., Yamashita, Y., & Takahashi, S. (2019) · Toxicology · doi:10.1016/j.tox.2019.152325 · Cited by 16
Impact of prenatal nicotine on the structure of midbrain dopamine regions in the rat
Omelchenko, N., Roy, P., Balcita‐Pedicino, J. J., Poloyac, S. M., & Sesack, S. R. (2015) · Brain Structure and Function · doi:10.1007/s00429-015-1014-y · Cited by 17
Smit‐McBride, Z., Nguyen, J., Elliott, G. W., Wang, Z., McBride, R. A., Nguyen, A. T., Oltjen, S. L., Yiu, G. C., Thomasy, S. M., Pinkerton, K. E., et al. (2018) · Europe PMC (PubMed Central) · Cited by 15
Miralles, P., López, A., Dualde, P., Coscollà, C., & Yusà, V. (2021) · Journal of Separation Science · doi:10.1002/jssc.202100205 · Cited by 15
Ilbäck, N.-G. (2003) · Toxicology Letters · doi:10.1016/s0378-4274(03)00155-3 · Cited by 15
Paul, S., Das, S., Mitra, B., Pariyar, G. C., & Ghosh, P. (2023) · RSC Advances · doi:10.1039/d2ra08054k · Cited by 14
Gubner, N. R., McKinnon, C. S., Reed, C. L., & Phillips, T. J. (2012) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2012.06.015 · Cited by 14
Wang, Y., Wan, B., Huang, J., & Clarke, P. B. S. (2020) · Psychopharmacology · doi:10.1007/s00213-020-05574-0 · Cited by 14
Pawlak, R., Takada, Y., Takahashi, H., Urano, T., Ihara, H., Nagai, N., & Takada, A. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(99)00778-5 · Cited by 14
Drug Transfer During Breast-Feeding
Hale, T. W., & Abbey, J. (2016) · Elsevier eBooks · doi:10.1016/b978-0-323-35214-7.00023-8 · Cited by 13
Xia, W., Veljkovic, E., Koshibu, K., Peitsch, M. C., & Hoeng, J. (2019) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2019.172809 · Cited by 13
Fe‐Catalyzed α‐C(sp3)−H Amination of N‐Heterocycles
Geraci, A., & Baudoin, O. (2024) · Angewandte Chemie International Edition · doi:10.1002/anie.202417414 · Cited by 12
Acute nicotine administration stimulates ciliary activity via α3β4 nAChR in the mouse trachea
Perniss, A., Latz, A., Boseva, I., Papadakis, T., Dames, C., Meisel, C., Meisel, A., Scholze, P., Kummer, W., & Krasteva‐Christ, G. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.106496 · Cited by 13
Nakhaee, M. R., Zolfaghari, M. R., Joukar, S., Nakhaee, N., Masoumi‐Ardakani, Y., Iranpour, M., & Nazari, M. (2020) · PubMed Central · doi:10.22122/ahj.v12i2.264 · Cited by 11
Schroff, K.-C., Lovich, P., Schmitz, O. J., Aschhoff, S., Richter, E., & Remien, J. (2000) · Toxicology · doi:10.1016/s0300-483x(99)00195-x · Cited by 11
Molecular mechanisms of pidolate magnesium action and its neurotropic affects
Громова, О. А., Torshin, I. Y., Геннадьевна, К. А., Федотова, Л. Э., & Владимирович, Р. К. (2016) · S S Korsakov Journal of Neurology and Psychiatry · doi:10.17116/jnevro201611612196-103 · Cited by 11
Luo, Y. R., Goodnough, R., Yun, C., Wu, A. H. B., & Lynch, K. L. (2021) · Journal of Analytical Toxicology · doi:10.1093/jat/bkab015 · Cited by 10
Lack of effect of 5HT3 antagonist in mediating subjective and behavioral responses to cotinine
Hatsukami, D. K., Jensen, J. A., Brauer, L. H., Mooney, M. E., Schulte, S., Sofuoglu, M., & Pentel, P. R. (2003) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(03)00035-2 · Cited by 10
Weera, M. M., Fields, M. A., Tapp, D. N., Grahame, N. J., & Chester, J. A. (2017) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.13555 · Cited by 8
DFT‐Aided Vibrational Circular Dichroism Spectroscopy Study of (−)‐S‐cotinine
Ortega, P. G. R., Montejo, M., Márquez, F., & González, J. J. L. (2015) · ChemPhysChem · doi:10.1002/cphc.201500018 · Cited by 7
Effects of Nicotine on Dopaminergic Neurotransmission
Rowell, P. P. (2001) · Frontiers in neuroscience · doi:10.1201/9781420038521.ch3 · Cited by 7
Relapse to cotinine seeking in rats: differential effects of sex
Tan, X., Neslund, E. M., & Ding, Z. (2022) · Behavioural Pharmacology · doi:10.1097/fbp.0000000000000696 · Cited by 7
Tan, X., Neslund, E. M., & Ding, Z. (2023) · Neuropharmacology · doi:10.1016/j.neuropharm.2023.109495 · Cited by 7
γ-Lactams and furan bispyrrolidines via iodine mediated cyclisation of homoallylamines
Salih, M. A. H., Male, L., Spencer, N., & Fossey, J. (2015) · Organic Chemistry Frontiers · doi:10.1039/c5qo00183h · Cited by 6
Pervaram, S., Ashok, D., Reddy, C. V. R., Sarasija, M., & Ganesh, A. (2020) · Chemical Data Collections · doi:10.1016/j.cdc.2020.100508 · Cited by 6
Fe‐Catalyzed α‐C(sp3)−H Amination of N‐Heterocycles
Geraci, A., & Baudoin, O. (2024) · Angewandte Chemie · doi:10.1002/ange.202417414 · Cited by 5
Zhukovsky, D., Dar’in, D. V., & Krasavin, M. (2020) · European Journal of Organic Chemistry · doi:10.1002/ejoc.202000067 · Cited by 5
Douroudgari, H., & Vahedpour, M. (2021) · Scientific Reports · doi:10.1038/s41598-021-01751-z · Cited by 5
Yang, X., Naylor, J. E., Matazel, K. S., Goodwin, A., Jacob, C. C., Bryant, M., Loukotková, L., da Costa, G. G., Chemerynski, S., Deng‐Bryant, Y., et al. (2019) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2019.114826 · Cited by 4
The involvement of mesolimbic dopamine system in cotinine self-administration in rats
Tan, X., Ingraham, C. M., McBride, W. J., & Ding, Z. (2021) · Behavioural Brain Research · doi:10.1016/j.bbr.2021.113596 · Cited by 5
Ding, Z., Neslund, E. M., Sun, D., & Tan, X. (2024) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntae063 · Cited by 3
Mal, K., & Mukhopadhyay, C. (2022) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2022.133377 · Cited by 3
Koh, Y.-Y., Jang, S.-J., & Lim, D. (2003) · Archives of Pharmacal Research · doi:10.1007/bf02976686 · Cited by 3
Hapten Design for Anti-addiction Vaccine Development
Collins, K. C., & Janda, K. D. (2015) · Springer eBooks · doi:10.1007/978-3-319-23150-1_18 · Cited by 2
Amiri, H. L., Javanbakht, M. H., Baghbanian, S. M., & Parsaeian, M. (2024) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2024.110845 · Cited by 2
The therapeutic potential of nicotine and nicotinic agonists for weight control
Gurwitz, D. (1999) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.8.6.747 · Cited by 2
Choudhury, P., & Basu, B. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-817592-7.00003-4 · Cited by 3
Gray, J. P., & Hall, G. J. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-386454-3.00294-3 · Cited by 2
Idrees, S. M., Waite, S. L., Granados-Aparici, S., & Fenwick, M. A. (2024) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2024.117302 · Cited by 1
Iravani, S., & Esmaeili, A. A. (2020) · Journal of Chemical Research · doi:10.1177/1747519820903291 · Cited by 1
Betti, N., Hussain, R. I., Kadhem, S. A., & Atia, A. J. K. (2020) · Journal of Al-Nahrain University-Science · doi:10.22401/anjs.23.4.02 · Cited by 1
Metadata
- Authors
- Dwoskin, L. P., Teng, L., Buxton, S. T., & Crooks, P. A.
- Affiliations
- University of Kentucky (US)
- Corresponding author
- Dwoskin, Linda P.
- ORCID
- Crooks, Peter A.
- Venue
- The Journal of Pharmacology and Experimental Therapeutics
- Publisher
- Elsevier BV
- Published
- 1999-03
- Volume
- 288
- Issue
- 3
- Pages
- 905-911
- ISSN
- 0022-3565 (ISSN-L)
- OpenAlex
- W1911378236
- Cited by
- 120
- References
- 73
- Citations by year
- 2026: 3 · 2025: 2 · 2024: 5 · 2023: 4 · 2022: 2 · 2021: 6 · 2020: 12 · 2019: 4 · 2018: 4 · 2017: 6 · 2016: 6 · 2015: 10 · 2014: 10 · 2013: 2 · 2012: 6
- FWCI
- 1.60
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Pharmacology and Experimental Therapeutics (publishedVersion)
- PubMed (publishedVersion)
- PubMed
- Funders
- National Institutes of Health (5r01da008656-03)
- National Institute on Drug Abuse (DA-08656)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nicotinic Acetylcholine Receptors Study
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Smoking Behavior and Cessation
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- cotinine, nicotine metabolites, nicotinic acetylcholine receptors, dopamine release, striatum, calcium dependence, receptor desensitization, mecamylamine, dihydro-beta-erythroidine, dopamine uptake, tobacco use
- MeSH terms
- Animals, Calcium, Corpus Striatum, Cotinine, Dopamine, Male, Nicotine, Receptors, Nicotinic, Synaptosomes, Tritium, Rats, Sprague-Dawley, Nicotinic Agonists, Nicotinic Antagonists, Rats, In Vitro Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
